Drug store chain CVS Caremark Corp., looking to build its West Coast presence, said Tuesday it would buy Longs Drug Stores Corp. in a deal valued at $2.7 billion.The $71.50 per-share cash offer, announced after the end of trading Tuesday, was a 32 percent premium over Walnut Creek, Calif.-based Longs' closing price of $54.04.
Longs' shares soared 30 percent, or $16.21, to $70.25 in after-hours trading.
Including the assumption of the chain's roughly $200 million in debt, the deal is valued at about $2.9 billion.
Link.
0 comments
Hide comments